Neurocompute Narrative Velocity Map
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative
Velocity Map

Explore the Parkinson’s research intelligence diagram before entering the Neurocompute platform.

NC
Neurocompute
AI Parkinson’s Intelligence Terminal
RESEARCH PAPER

Histamine H4 receptor in neuroinflammation: Dual roles in multiple sclerosis and Parkinson's disease.

PMID
41997459
Journal
Neurobiology of disease
Publication Date
2026-04-15
Grade
D

AI Summary

This review synthesizes evidence that the histamine H4 receptor (H4R) exerts context-dependent, dual roles in neuroinflammation—promoting NF-κB/MAPK-driven pro-inflammatory microglial and T-cell responses that worsen MS and PD pathology while under some conditions engaging JAK/STAT/PI3K-Akt…

Why It Matters

H4R is a druggable GPCR with existing ligands, so resolving its cell- and disease-stage specific signaling bias could enable repurposing or development of H4R-targeted therapies to modulate neuroinflammation and potentially protect dopaminergic neurons in Parkinson's disease.

Abstract

Neuroinflammation plays a pivotal role in the progression of neurodegenerative disorders such as multiple sclerosis (MS) and Parkinson's disease (PD), primarily through a self-amplifying positive feedback loop between inflammation and neurodegeneration. The histamine H4 receptor (H4R), expressed on both peripheral immune cells and central microglia, serves as a critical molecular interface linking peripheral immunity to central nervous system inflammation. This review provides a systematic analysis of the context-dependent, dual roles of H4R in neuroinflammatory processes underlying MS and PD. In the context of MS and its experimental autoimmune encephalomyelitis (EAE) model, H4R activation promotes NF-κB signaling and upregulates pro-inflammatory mediators including TNF-α and IL-6, thereby driving the differentiation of pathogenic T-helper subsets (Th1, Th9, and Th17) and exacerbating disease pathology. Paradoxically, H4R signaling may also support early immune homeostasis by facilitating the expansion and functional maturation of regulatory T cells. In PD, elevated H4R expression correlates with increased disease severity. H4R activation drives microglial polarization toward a pro-inflammatory phenotype and stimulates the release of inflammatory cytokines via NF-κB and MAPK signaling pathways, ultimately contributing to dopaminergic neuron loss. Conversely, under specific physiological or pharmacological conditions, H4R engagement can promote anti-inflammatory microglial polarization through the JAK/STAT/PI3K/Akt signaling cascade. The functional complexity of H4R arises from factors such as cell-type specificity, disease stage, ligand-biased signaling, and variations across experimental models. A deeper understanding of the dual regulatory mechanisms of H4R and its therapeutic potential will offer valuable insights for the development of novel strategies targeting neuroinflammatory pathways.

Score Breakdown

AI Score
62.0
Base Score
50.0
Rank Score
48.5
Narrative Velocity
-
AI Confidence
-
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic
Full Neurocompute Infographic